Meta-analysis of 10 studies (6962 people with HIV): the VISITECT CD4 lateral-flow assay had pooled sensitivity 98% and specificity 71% versus flow cytometry for advanced HIV disease, meeting the ≥90% sensitivity target but below the ≥80% specificity target.
Meta-analysisn = 6,962
Gebremeskele et al. Diagnostic accuracy of the VISITECT CD4 lateral-flow assay for screening advanced HIV disease: A systematic review and meta-analysis